Inflammatory Breast Cancer Overview
Learn About Inflammatory Breast Cancer
View Main Condition: Breast Cancer
- Inflammatory breast cancer
- Breast cancer, inflammatory
MD Anderson
Henry Kuerer is a Surgical Oncologist in Houston, Texas. Dr. Kuerer is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Alastair Thompson is a Surgical Oncologist and a General Surgeon in Houston, Texas. Dr. Thompson is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy. Dr. Thompson is currently accepting new patients.
Yale University
Eric Winer is an Oncologist and a Hematologist Oncology provider in New Haven, Connecticut. Dr. Winer is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Breast Cancer in Men.
Summary: The purpose of this study is to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn whether the intervention works in treating Human Epidermal growth factor Receptor-2 (HER2)-expressing inflammatory breast cancer. The names of the study drugs involved in this study are: * Trastuzumab deruxtecan * Durvalumab
Summary: This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory breast cancer that has spread to nearby tissues or lymph nodes or melanoma. The lymphovenous bypass procedure creates a path for lymphatic fluid to flow away from the arms. It is usually done after a diagnosis of lymphedema....
Published Date: May 13, 2022
Published By: Genetic and Rare Diseases Informnation Center


